Until 2024, the Norameda Special Care Medicine Department has been actively working with two main rare diseases: Alpha-mannosidosis and Hereditary Leber optic Neuropathy. This year, Norameda introduced a new option in treating Fabry disease and is entering a new field...

At the end of 2023, an Amendment to the Reimbursement Act came into force in Poland. We present the main changes with the comment from the CEO of Norameda of the Polish Branch, Arvydas Norvaišas. "Poland's pharmaceutical community has met these amendments with a...

With twenty years of experience in the pharmaceutical field most of his career at Pfizer, Ivan Chervotkin joined the Norameda team as Alliance Manager for Baltic states in spring 2023. "The company is one I have long admired for its business-oriented approach and...

Rasa Kalėdaitė, PhD Qualified Person and Head of the Norameda Quality Division, wants to draw attention to medicine storage at home, especially in summer. Medicines and medical devices used at home can be stored in two different temperature regimes: room temperature -...